A Platinum Resistance-Related lncRNA Signature for Risk Classification and Prognosis Prediction in Patients with Serous Ovarian Cancer.
J Oncol
; 2022: 7625138, 2022.
Article
in En
| MEDLINE
| ID: mdl-37223641
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
J Oncol
Year:
2022
Document type:
Article
Affiliation country:
China
Country of publication:
Egypt